Corrigendum: Chronic Intra-Uterine Ureaplasma parvum infection induces injury of the enteric Nervous System in Ovine Fetuses

Michael L. Beeton was not included as an author in the published article. The corrected Author Contributions Statement appears below

Screening of Chorioamnionitis Using Volatile Organic Compound Detection in Exhaled Breath: A Pre-clinical Proof of Concept Study

Chorioamnionitis is a major risk factor for preterm birth and an independent risk factor for postnatal morbidity for which currently successful therapies are lacking. Emerging evidence indicates that the timing and duration of intra-amniotic infections are crucial determinants for the stage of developmental injury at birth. Insight into the dynamical changes of organ injury after the onset of chorioamnionitis revealed novel therapeutic windows of opportunity. Importantly, successful development and implementation of therapies in clinical care is currently impeded by a lack of diagnostic tools for early (prenatal) detection and surveillance of intra-amniotic infections. In the current study we questioned whether an intra-amniotic infection could be accurately diagnosed by a specific volatile organic compound (VOC) profile in exhaled breath of pregnant sheep. For this purpose pregnant Texel ewes were inoculated intra-amniotically with Ureaplasma parvum and serial collections of exhaled breath were performed for 6 days. Ureaplasma parvum infection induced a distinct VOC-signature in expired breath of pregnant sheep that was significantly different between day 0 and 1 vs. day 5 and 6. Based on a profile of only 15 discriminatory volatiles, animals could correctly be classified as either infected (day 5 and 6) or not (day 0 and 1) with a sensitivity of 83% and a specificity of 71% and an area under the curve of 0.93. Chemical identification of these distinct VOCs revealed the presence of a lipid peroxidation marker nonanal and various hydrocarbons including n-undecane and n-dodecane. These data indicate that intra-amniotic infections can be detected by VOC analyses of exhaled breath and might provide insight into temporal dynamics of intra-amniotic infection and its underlying pathways. In particular, several of these volatiles are associated with enhanced oxidative stress and undecane and dodecane have been reported as predictive biomarker of spontaneous preterm birth in humans. Applying VOC analysis for the early detection of intra-amniotic infections will lead to appropriate surveillance of these high-risk pregnancies, thereby facilitating appropriate clinical course of action including early treatment of preventative measures for pre-maturity-associated morbidities

Monte Carlo studies for the optimisation of the Cherenkov Telescope Array layout

International audienceThe Cherenkov Telescope Array (CTA) is the major next-generation observatory for ground-based very-high-energy gamma-ray astronomy. It will improve the sensitivity of current ground-based instruments by a factor of five to twenty, depending on the energy, greatly improving both their angular and energy resolutions over four decades in energy (from 20 GeV to 300 TeV). This achievement will be possible by using tens of imaging Cherenkov telescopes of three successive sizes. They will be arranged into two arrays, one per hemisphere, located on the La Palma island (Spain) and in Paranal (Chile). We present here the optimised and final telescope arrays for both CTA sites, as well as their foreseen performance, resulting from the analysis of three different large-scale Monte Carlo productions

Science with the Cherenkov Telescope Array

The Cherenkov Telescope Array, CTA, will be the major global observatory forvery high energy gamma-ray astronomy over the next decade and beyond. Thescientific potential of CTA is extremely broad: from understanding the role ofrelativistic cosmic particles to the search for dark matter. CTA is an explorerof the extreme universe, probing environments from the immediate neighbourhoodof black holes to cosmic voids on the largest scales. Covering a huge range inphoton energy from 20 GeV to 300 TeV, CTA will improve on all aspects ofperformance with respect to current instruments. The observatory will operate arrays on sites in both hemispheres to providefull sky coverage and will hence maximize the potential for the rarestphenomena such as very nearby supernovae, gamma-ray bursts or gravitationalwave transients. With 99 telescopes on the southern site and 19 telescopes onthe northern site, flexible operation will be possible, with sub-arraysavailable for specific tasks. CTA will have important synergies with many ofthe new generation of major astronomical and astroparticle observatories.Multi-wavelength and multi-messenger approaches combining CTA data with thosefrom other instruments will lead to a deeper understanding of the broad-bandnon-thermal properties of target sources. The CTA Observatory will be operated as an open, proposal-driven observatory,with all data available on a public archive after a pre-defined proprietaryperiod. Scientists from institutions worldwide have combined together to formthe CTA Consortium. This Consortium has prepared a proposal for a CoreProgramme of highly motivated observations. The programme, encompassingapproximately 40% of the available observing time over the first ten years ofCTA operation, is made up of individual Key Science Projects (KSPs), which arepresented in this document